Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 11, 2009, Pages 1830-1834

  Proesmans, M ^a   Sauer, K ^a   Govaere, E ^d   Raes, M ^b   De Bilderling, G ^c   De Boeck, K ^a  

^a Department of Pediatrics   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c Pediatric Pulmonology Centre   (Belgium)

^d OLV HOSPITAL   (Belgium)

Author keywords

Bronchiolitis; Cough; LTRA; Montelukast; RSV; Wheeze

Indexed keywords

ADRENALIN; BRONCHODILATING AGENT; BUDESONIDE; INFUSION FLUID; MONTELUKAST; OXYGEN; PLACEBO;

ARTICLE; CHILD; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; NIGHT; OXYGEN THERAPY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; SYMPTOM; VIRAL BRONCHIOLITIS; WHEEZING;

ACETATES; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; COUGH; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFANT; PROSPECTIVE STUDIES; QUINOLINES; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 70350520315     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01463.x     Document Type: Article

References (23)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis associated hospitalizations among US children, 1980-1996. JAMA 1999 20 : 1440 1446.
2. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory virus-associated deaths among US children, 1979-1997. J Infect Dis 2001 183 : 16 22.
3. Boyce TG, Mellen BG, Mitchel EF Jr., Wright PF, Griffin MR. Rates of hospitalization for respiratory syncitial virus infection among children in Medicaid. J Pediatr 2000 137 : 865 870.
4. Devincenzo JP. Natural infection with respiratory synctytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Pediatr Res 2004 56 : 914 917.
5. Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med 2001 163 : S2 6.
6. Noble V, Murray M, Webb MS, Alexander J, Swarbrick AS, Milner AD. Respiratory status and allergy nine to 10 years after bronchiolitis. Arch Dis Child 1977 76 : 315 319.
7. Sims DG, Downham MA, Gardner PS, Webb JK, Weightman D. Study of 8 year old children with a history of respiratory syncitial virus bronchiolitis in infancy. BMJ 1978 1 : 11 4.
8. Schauer U, Hoffjan S, Bittscheidt J, Kochling A, Hemmis S, Bongartz S, et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 2002 20 : 1277 1283.
9. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncitial virus in early life and risk of wheeze and allergy by age 13. Lancet 1999 354 : 541 545.
10. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005 16 : 386 392.
11. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005 171 : 137 141.
12. Goetghebuer T, Isles K, Moore C, Thomson A, Kwiatkowski D, Hull J. Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004 34 : 801 803.
13. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003 22 : S76 82.
14. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II., Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999 103 : 630 636.
15. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988 24 : 504 507.
16. Kim CK, Koh JY, Han TH, Kim do K, Kim BI, Koh YY. Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis. Acta Paediatr 2006 95 : 479 485.
17. Piedimonte G, Renzetti G, Auais A, Di Marco A, Tripodi S, Colistro F, et al. Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy. Pediatr Pulmonol 2005 40 : 285 291.
18. Da Dalt L, Callegaro S, Carraro S, Andreola B, Corradi M, Baraldi E. Nasal lavage leukotrienes in infants with RSV bronchiolitis. Pediatr Allergy Immunol 2007 18 : 100 104.
19. Bisgaard H. Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003 167 : 379 383.
20. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, et al. Study of montelukast for the treatment of respiratory symptoms of post-RSV-bronchiolitis in children. Am J Respir Crit Care Med 2008 178 : 854 860.
21. Santanello NC, Demuro-Mercon C, Davies G, Ostrom N, Noonan M, Rooklin A, et al. Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol 2000 106 : 861 866.
22. Piedimonte G, Rodriguez M, King K, McLean S, Jiang X. Respiratory syncitial virus upregulates expression of substance P receptor in rat lungs. Am J Physiol 1999 277 : L831 40.
23. Elphick HE, Ritson S, Rigby AS, Everard ML. Phenotype of acute respiratory syncytial virus induced lower respiratory tract illness in infancy and subsequent morbidity. Acta Paediatr 2007 96 : 307 309.